Vertex Stands Ready To Launch First Drug In Its Pain Franchise

NaV Channel Research Has Been A Long Journey

Vertex may win US FDA approval in January for the first novel pain drug in decades, after investing a lot of time and inventing new technology to unravel the science behind suzetrigine.

Vertex's suzetrigine launch is on track for early 2025, pending US FDA approval (Shutterstock)

More from Strategy

More from Scrip